These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38971786)

  • 21. Chloroquine has shown high therapeutic efficacy against uncomplicated Plasmodium vivax malaria in southern Ethiopia: seven decades after its introduction.
    Mare AK; Mohammed H; Sime H; Hailgiorgis H; Gubae K; Gidey B; Haile M; Assefa G; Bekele W; Auburn S; Price R; Parr JB; Juliano JJ; Tasew G; Abay SM; Assefa A
    Malar J; 2024 Jun; 23(1):183. PubMed ID: 38858696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria.
    Chu CS; Phyo AP; Turner C; Win HH; Poe NP; Yotyingaphiram W; Thinraow S; Wilairisak P; Raksapraidee R; Carrara VI; Paw MK; Wiladphaingern J; Proux S; Bancone G; Sriprawat K; Lee SJ; Jeeyapant A; Watson J; Tarning J; Imwong M; Nosten F; White NJ
    Clin Infect Dis; 2019 Apr; 68(8):1311-1319. PubMed ID: 30952158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic efficacy of chloroquine for treatment of Plasmodium vivax malaria cases in Guragae zone southern Central Ethiopia.
    Shumbej T; Jemal A; Worku A; Bekele F; Weldesenbet H
    BMC Infect Dis; 2019 May; 19(1):413. PubMed ID: 31088384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial.
    Taylor WRJ; Thriemer K; von Seidlein L; Yuentrakul P; Assawariyathipat T; Assefa A; Auburn S; Chand K; Chau NH; Cheah PY; Dong LT; Dhorda M; Degaga TS; Devine A; Ekawati LL; Fahmi F; Hailu A; Hasanzai MA; Hien TT; Khu H; Ley B; Lubell Y; Marfurt J; Mohammad H; Moore KA; Naddim MN; Pasaribu AP; Pasaribu S; Promnarate C; Rahim AG; Sirithiranont P; Solomon H; Sudoyo H; Sutanto I; Thanh NV; Tuyet-Trinh NT; Waithira N; Woyessa A; Yamin FY; Dondorp A; Simpson JA; Baird JK; White NJ; Day NP; Price RN
    Lancet; 2019 Sep; 394(10202):929-938. PubMed ID: 31327563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis.
    Commons RJ; Simpson JA; Thriemer K; Humphreys GS; Abreha T; Alemu SG; Añez A; Anstey NM; Awab GR; Baird JK; Barber BE; Borghini-Fuhrer I; Chu CS; D'Alessandro U; Dahal P; Daher A; de Vries PJ; Erhart A; Gomes MSM; Gonzalez-Ceron L; Grigg MJ; Heidari A; Hwang J; Kager PA; Ketema T; Khan WA; Lacerda MVG; Leslie T; Ley B; Lidia K; Monteiro WM; Nosten F; Pereira DB; Phan GT; Phyo AP; Rowland M; Saravu K; Sibley CH; Siqueira AM; Stepniewska K; Sutanto I; Taylor WRJ; Thwaites G; Tran BQ; Tran HT; Valecha N; Vieira JLF; Wangchuk S; William T; Woodrow CJ; Zuluaga-Idarraga L; Guerin PJ; White NJ; Price RN
    Lancet Infect Dis; 2018 Sep; 18(9):1025-1034. PubMed ID: 30033231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety, efficacy and pharmacokinetic evaluations of a new coated chloroquine tablet in a single-arm open-label non-comparative trial in Brazil: a step towards a user-friendly malaria vivax treatment.
    Pereira D; Daher A; Zanini G; Maia I; Fonseca L; Pitta L; Ruffato R; Marchesini P; Fontes CJ
    Malar J; 2016 Sep; 15():477. PubMed ID: 27639847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India.
    Saravu K; Kumar R; Ashok H; Kundapura P; Kamath V; Kamath A; Mukhopadhyay C
    PLoS One; 2016; 11(6):e0157666. PubMed ID: 27315280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia.
    Teka H; Petros B; Yamuah L; Tesfaye G; Elhassan I; Muchohi S; Kokwaro G; Aseffa A; Engers H
    Malar J; 2008 Oct; 7():220. PubMed ID: 18959774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria.
    Chu CS; Phyo AP; Lwin KM; Win HH; San T; Aung AA; Raksapraidee R; Carrara VI; Bancone G; Watson J; Moore KA; Wiladphaingern J; Proux S; Sriprawat K; Winterberg M; Cheah PY; Chue AL; Tarning J; Imwong M; Nosten F; White NJ
    Clin Infect Dis; 2018 Oct; 67(10):1543-1549. PubMed ID: 29889239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of an Unsupervised Primaquine Regimen for Preventing Plasmodium vivax Malaria Relapses in Northeast Myanmar: A Single-Arm Nonrandomized Observational Study.
    Malla P; Wang Z; Brashear A; Yang Z; Lo E; Baird K; Wang C; Cui L
    J Infect Dis; 2024 May; 229(5):1557-1564. PubMed ID: 38041857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern Myanmar.
    Yuan L; Wang Y; Parker DM; Gupta B; Yang Z; Liu H; Fan Q; Cao Y; Xiao Y; Lee MC; Zhou G; Yan G; Baird JK; Cui L
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1230-5. PubMed ID: 25512415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine.
    Galappaththy GN; Tharyan P; Kirubakaran R
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD004389. PubMed ID: 24163057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine combined with primaquine for radical treatment of vivax malaria in Sumatera, Indonesia.
    Pasaribu AP; Chokejindachai W; Sirivichayakul C; Tanomsing N; Chavez I; Tjitra E; Pasaribu S; Imwong M; White NJ; Dondorp AM
    J Infect Dis; 2013 Dec; 208(11):1906-13. PubMed ID: 23926329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India.
    Yadav RS; Ghosh SK
    J Parasitol; 2002 Oct; 88(5):1042-4. PubMed ID: 12435158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo efficacy of anti-malarial drugs against clinical Plasmodium vivax malaria in Ethiopia: a systematic review and meta-analysis.
    Ketema T; Bacha K; Getahun K; Bassat Q
    Malar J; 2021 Dec; 20(1):483. PubMed ID: 34952581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Where chloroquine still works: the genetic make-up and susceptibility of Plasmodium vivax to chloroquine plus primaquine in Bhutan.
    Wangchuk S; Drukpa T; Penjor K; Peldon T; Dorjey Y; Dorji K; Chhetri V; Trimarsanto H; To S; Murphy A; von Seidlein L; Price RN; Thriemer K; Auburn S
    Malar J; 2016 May; 15(1):277. PubMed ID: 27176722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border.
    Takeuchi R; Lawpoolsri S; Imwong M; Kobayashi J; Kaewkungwal J; Pukrittayakamee S; Puangsa-art S; Thanyavanich N; Maneeboonyang W; Day NP; Singhasivanon P
    Malar J; 2010 Nov; 9():308. PubMed ID: 21040545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.
    Vijaykadga S; Rojanawatsirivej C; Congpoung K; Wilairatana P; Satimai W; Uaekowitchai C; Pumborplub B; Sittimongkol S; Pinyorattanachote A; Prigchoo P
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):566-9. PubMed ID: 15689067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic efficacy of chloroquine for the treatment of Plasmodium vivax malaria among outpatients at Shawa Robit Health Care Centre, North-East Ethiopia.
    Seifu S; Zeynudin A; Zemene E; Suleman S; Biruksew A
    Acta Trop; 2017 Jul; 171():44-51. PubMed ID: 28300558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher-Dose Primaquine to Prevent Relapse of
    Chamma-Siqueira NN; Negreiros SC; Ballard SB; Farias S; Silva SP; Chenet SM; Santos EJM; Pereira de Sena LW; Póvoa da Costa F; Cardoso-Mello AGN; Marchesini PB; Peterka CRL; Viana GMR; Macedo de Oliveira A
    N Engl J Med; 2022 Mar; 386(13):1244-1253. PubMed ID: 35353962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.